nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertindole—DRD4—conduct disorder	0.429	0.485	CbGaD
Sertindole—SLC6A4—conduct disorder	0.258	0.291	CbGaD
Sertindole—HTR2A—conduct disorder	0.198	0.224	CbGaD
Sertindole—Haloperidol—DRD4—conduct disorder	0.00211	0.509	CrCbGaD
Sertindole—HTR2A—autonomic nervous system—conduct disorder	0.00131	0.185	CbGeAlD
Sertindole—Pimozide—HTR2A—conduct disorder	0.00107	0.257	CrCbGaD
Sertindole—Haloperidol—HTR2A—conduct disorder	0.000973	0.235	CrCbGaD
Sertindole—DRD4—brain—conduct disorder	0.000648	0.0912	CbGeAlD
Sertindole—HTR1F—brain—conduct disorder	0.000645	0.0908	CbGeAlD
Sertindole—HTR1E—brain—conduct disorder	0.000558	0.0787	CbGeAlD
Sertindole—DRD3—brain—conduct disorder	0.000455	0.0641	CbGeAlD
Sertindole—HTR6—brain—conduct disorder	0.000438	0.0617	CbGeAlD
Sertindole—ADRA1B—brain—conduct disorder	0.00035	0.0493	CbGeAlD
Sertindole—ADRA1D—brain—conduct disorder	0.000342	0.0482	CbGeAlD
Sertindole—HTR1B—brain—conduct disorder	0.000264	0.0372	CbGeAlD
Sertindole—HTR1D—brain—conduct disorder	0.000256	0.036	CbGeAlD
Sertindole—HTR2C—brain—conduct disorder	0.000253	0.0357	CbGeAlD
Sertindole—SLC6A4—brain—conduct disorder	0.00024	0.0338	CbGeAlD
Sertindole—HTR1A—brain—conduct disorder	0.000213	0.03	CbGeAlD
Sertindole—ADRA1A—brain—conduct disorder	0.000196	0.0277	CbGeAlD
Sertindole—DRD2—brain—conduct disorder	0.000193	0.0271	CbGeAlD
Sertindole—KCNH2—brain—conduct disorder	0.00019	0.0267	CbGeAlD
Sertindole—HRH1—brain—conduct disorder	0.000152	0.0214	CbGeAlD
Sertindole—ADRA2A—brain—conduct disorder	0.000149	0.021	CbGeAlD
Sertindole—HTR2A—brain—conduct disorder	0.000127	0.0179	CbGeAlD
Sertindole—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000121	0.00117	CbGpPWpGaD
Sertindole—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000119	0.00115	CbGpPWpGaD
Sertindole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000118	0.00113	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—CGA—conduct disorder	0.000117	0.00112	CbGpPWpGaD
Sertindole—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000116	0.00112	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—CGA—conduct disorder	0.000116	0.00111	CbGpPWpGaD
Sertindole—CYP2D6—brain—conduct disorder	0.000116	0.0163	CbGeAlD
Sertindole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000114	0.00109	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—CGA—conduct disorder	0.000113	0.00109	CbGpPWpGaD
Sertindole—HTR1F—GPCR downstream signaling—DRD4—conduct disorder	0.000112	0.00107	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—CGA—conduct disorder	0.000112	0.00107	CbGpPWpGaD
Sertindole—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.000109	0.00105	CbGpPWpGaD
Sertindole—DRD3—GPCR downstream signaling—CGA—conduct disorder	0.000109	0.00105	CbGpPWpGaD
Sertindole—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000109	0.00105	CbGpPWpGaD
Sertindole—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000109	0.00105	CbGpPWpGaD
Sertindole—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000108	0.00104	CbGpPWpGaD
Sertindole—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000108	0.00104	CbGpPWpGaD
Sertindole—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000108	0.00104	CbGpPWpGaD
Sertindole—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000108	0.00104	CbGpPWpGaD
Sertindole—DRD3—GPCR ligand binding—DRD4—conduct disorder	0.000108	0.00104	CbGpPWpGaD
Sertindole—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.000108	0.00104	CbGpPWpGaD
Sertindole—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000107	0.00103	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—CGA—conduct disorder	0.000107	0.00103	CbGpPWpGaD
Sertindole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000107	0.00103	CbGpPWpGaD
Sertindole—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000107	0.00103	CbGpPWpGaD
Sertindole—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000106	0.00102	CbGpPWpGaD
Sertindole—HTR1E—GPCR downstream signaling—DRD4—conduct disorder	0.000105	0.00101	CbGpPWpGaD
Sertindole—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000105	0.00101	CbGpPWpGaD
Sertindole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000105	0.00101	CbGpPWpGaD
Sertindole—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000104	0.001	CbGpPWpGaD
Sertindole—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000104	0.000999	CbGpPWpGaD
Sertindole—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000103	0.000993	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—DRD4—conduct disorder	0.000101	0.000976	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—CGA—conduct disorder	0.000101	0.000971	CbGpPWpGaD
Sertindole—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000101	0.00097	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—CGA—conduct disorder	9.91e-05	0.000954	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—CGA—conduct disorder	9.91e-05	0.000954	CbGpPWpGaD
Sertindole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	9.73e-05	0.000936	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—DRD4—conduct disorder	9.57e-05	0.00092	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—CGA—conduct disorder	9.51e-05	0.000915	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—CGA—conduct disorder	9.46e-05	0.00091	CbGpPWpGaD
Sertindole—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.43e-05	0.000907	CbGpPWpGaD
Sertindole—HTR1A—GPCR ligand binding—DRD4—conduct disorder	9.43e-05	0.000907	CbGpPWpGaD
Sertindole—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	9.4e-05	0.000905	CbGpPWpGaD
Sertindole—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	9.38e-05	0.000902	CbGpPWpGaD
Sertindole—HTR2C—GPCR ligand binding—DRD4—conduct disorder	9.38e-05	0.000902	CbGpPWpGaD
Sertindole—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.27e-05	0.000892	CbGpPWpGaD
Sertindole—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	9.27e-05	0.000892	CbGpPWpGaD
Sertindole—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	9.23e-05	0.000888	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	9.06e-05	0.000872	CbGpPWpGaD
Sertindole—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.98e-05	0.000864	CbGpPWpGaD
Sertindole—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	8.98e-05	0.000864	CbGpPWpGaD
Sertindole—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	8.75e-05	0.000842	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—CGA—conduct disorder	8.64e-05	0.000831	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—CGA—conduct disorder	8.59e-05	0.000827	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—WASF1—conduct disorder	8.57e-05	0.000825	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—CGA—conduct disorder	8.35e-05	0.000804	CbGpPWpGaD
Sertindole—HTR6—GPCR ligand binding—HTR2A—conduct disorder	8.31e-05	0.000799	CbGpPWpGaD
Sertindole—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.28e-05	0.000796	CbGpPWpGaD
Sertindole—DRD2—GPCR ligand binding—DRD4—conduct disorder	8.28e-05	0.000796	CbGpPWpGaD
Sertindole—CYP2D6—Biological oxidations—COMT—conduct disorder	8.25e-05	0.000794	CbGpPWpGaD
Sertindole—HTR1D—GPCR ligand binding—HTR2A—conduct disorder	8.24e-05	0.000793	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—CGA—conduct disorder	8.23e-05	0.000791	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—CGA—conduct disorder	8.22e-05	0.000791	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—CGA—conduct disorder	8.2e-05	0.000789	CbGpPWpGaD
Sertindole—CYP2D6—Biological oxidations—MAOA—conduct disorder	8.19e-05	0.000788	CbGpPWpGaD
Sertindole—HTR2A—GPCR ligand binding—DRD4—conduct disorder	8.14e-05	0.000784	CbGpPWpGaD
Sertindole—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	8.14e-05	0.000783	CbGpPWpGaD
Sertindole—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.13e-05	0.000782	CbGpPWpGaD
Sertindole—HRH1—GPCR ligand binding—DRD4—conduct disorder	8.13e-05	0.000782	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—WASF1—conduct disorder	8.09e-05	0.000778	CbGpPWpGaD
Sertindole—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.08e-05	0.000777	CbGpPWpGaD
Sertindole—HTR1B—GPCR ligand binding—HTR2A—conduct disorder	8.07e-05	0.000777	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	8.05e-05	0.000774	CbGpPWpGaD
Sertindole—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.03e-05	0.000773	CbGpPWpGaD
Sertindole—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.97e-05	0.000767	CbGpPWpGaD
Sertindole—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	7.97e-05	0.000767	CbGpPWpGaD
Sertindole—DRD4—GPCR ligand binding—HTR2A—conduct disorder	7.94e-05	0.000764	CbGpPWpGaD
Sertindole—DRD4—Circadian rythm related genes—EP300—conduct disorder	7.88e-05	0.000758	CbGpPWpGaD
Sertindole—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.69e-05	0.00074	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—CGA—conduct disorder	7.58e-05	0.00073	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	7.48e-05	0.000719	CbGpPWpGaD
Sertindole—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	7.47e-05	0.000719	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—CGA—conduct disorder	7.46e-05	0.000718	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—CGA—conduct disorder	7.45e-05	0.000716	CbGpPWpGaD
Sertindole—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.41e-05	0.000713	CbGpPWpGaD
Sertindole—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	7.41e-05	0.000713	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—CGA—conduct disorder	7.31e-05	0.000703	CbGpPWpGaD
Sertindole—HTR1F—GPCR downstream signaling—HTR2A—conduct disorder	7.29e-05	0.000701	CbGpPWpGaD
Sertindole—HTR6—GPCR downstream signaling—DRD4—conduct disorder	7.2e-05	0.000692	CbGpPWpGaD
Sertindole—HTR1D—GPCR downstream signaling—DRD4—conduct disorder	7.14e-05	0.000687	CbGpPWpGaD
Sertindole—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.09e-05	0.000682	CbGpPWpGaD
Sertindole—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	7.06e-05	0.000679	CbGpPWpGaD
Sertindole—DRD3—GPCR ligand binding—HTR2A—conduct disorder	7.06e-05	0.000679	CbGpPWpGaD
Sertindole—DRD3—Circadian rythm related genes—EP300—conduct disorder	7e-05	0.000673	CbGpPWpGaD
Sertindole—HTR1B—GPCR downstream signaling—DRD4—conduct disorder	6.99e-05	0.000673	CbGpPWpGaD
Sertindole—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.96e-05	0.00067	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—CGA—conduct disorder	6.89e-05	0.000663	CbGpPWpGaD
Sertindole—HTR1E—GPCR downstream signaling—HTR2A—conduct disorder	6.87e-05	0.000661	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—CGA—conduct disorder	6.84e-05	0.000658	CbGpPWpGaD
Sertindole—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.83e-05	0.000657	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—CGA—conduct disorder	6.79e-05	0.000653	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—CGA—conduct disorder	6.7e-05	0.000644	CbGpPWpGaD
Sertindole—HTR1F—Signaling by GPCR—HTR2A—conduct disorder	6.62e-05	0.000637	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—CGA—conduct disorder	6.59e-05	0.000634	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—DRD4—conduct disorder	6.53e-05	0.000629	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—DRD4—conduct disorder	6.48e-05	0.000624	CbGpPWpGaD
Sertindole—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	6.45e-05	0.000621	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—DRD4—conduct disorder	6.35e-05	0.000611	CbGpPWpGaD
Sertindole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.35e-05	0.000611	CbGpPWpGaD
Sertindole—HTR1E—Signaling by GPCR—HTR2A—conduct disorder	6.24e-05	0.000601	CbGpPWpGaD
Sertindole—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	6.15e-05	0.000592	CbGpPWpGaD
Sertindole—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	6.12e-05	0.000589	CbGpPWpGaD
Sertindole—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	6.11e-05	0.000588	CbGpPWpGaD
Sertindole—DRD3—GPCR downstream signaling—DRD4—conduct disorder	6.11e-05	0.000588	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—DRD4—conduct disorder	5.99e-05	0.000576	CbGpPWpGaD
Sertindole—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	5.86e-05	0.000564	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—CGA—conduct disorder	5.85e-05	0.000563	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—CGA—conduct disorder	5.85e-05	0.000563	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—DRD4—conduct disorder	5.65e-05	0.000544	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	5.55e-05	0.000534	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—DRD4—conduct disorder	5.55e-05	0.000534	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—WASF1—conduct disorder	5.52e-05	0.000532	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—WASF1—conduct disorder	5.48e-05	0.000528	CbGpPWpGaD
Sertindole—DRD2—GPCR ligand binding—HTR2A—conduct disorder	5.4e-05	0.00052	CbGpPWpGaD
Sertindole—CYP3A4—Biological oxidations—COMT—conduct disorder	5.39e-05	0.000519	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—WASF1—conduct disorder	5.37e-05	0.000517	CbGpPWpGaD
Sertindole—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.36e-05	0.000515	CbGpPWpGaD
Sertindole—DRD2—Circadian rythm related genes—EP300—conduct disorder	5.35e-05	0.000515	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	5.33e-05	0.000513	CbGpPWpGaD
Sertindole—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	5.32e-05	0.000512	CbGpPWpGaD
Sertindole—HRH1—GPCR ligand binding—HTR2A—conduct disorder	5.3e-05	0.00051	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	5.3e-05	0.00051	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—WASF1—conduct disorder	5.28e-05	0.000508	CbGpPWpGaD
Sertindole—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	5.2e-05	0.000501	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—CGA—conduct disorder	5.1e-05	0.000491	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—CGA—conduct disorder	5.08e-05	0.000488	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	5.07e-05	0.000488	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—CGA—conduct disorder	4.86e-05	0.000468	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—DRD4—conduct disorder	4.84e-05	0.000465	CbGpPWpGaD
Sertindole—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	4.83e-05	0.000465	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—DRD4—conduct disorder	4.81e-05	0.000463	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—CGA—conduct disorder	4.8e-05	0.000461	CbGpPWpGaD
Sertindole—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	4.69e-05	0.000452	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—WASF1—conduct disorder	4.69e-05	0.000451	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—WASF1—conduct disorder	4.69e-05	0.000451	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—DRD4—conduct disorder	4.68e-05	0.00045	CbGpPWpGaD
Sertindole—HTR1D—GPCR downstream signaling—HTR2A—conduct disorder	4.66e-05	0.000448	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	4.61e-05	0.000443	CbGpPWpGaD
Sertindole—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	4.6e-05	0.000443	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—DRD4—conduct disorder	4.59e-05	0.000442	CbGpPWpGaD
Sertindole—HTR1B—GPCR downstream signaling—HTR2A—conduct disorder	4.56e-05	0.000439	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	4.51e-05	0.000434	CbGpPWpGaD
Sertindole—DRD4—GPCR downstream signaling—HTR2A—conduct disorder	4.49e-05	0.000432	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—CGA—conduct disorder	4.48e-05	0.000431	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—CGA—conduct disorder	4.41e-05	0.000424	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—CGA—conduct disorder	4.4e-05	0.000423	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—CGA—conduct disorder	4.32e-05	0.000415	CbGpPWpGaD
Sertindole—HTR6—Signaling by GPCR—HTR2A—conduct disorder	4.26e-05	0.00041	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—DRD4—conduct disorder	4.25e-05	0.000409	CbGpPWpGaD
Sertindole—HTR1D—Signaling by GPCR—HTR2A—conduct disorder	4.23e-05	0.000407	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	4.19e-05	0.000403	CbGpPWpGaD
Sertindole—HTR2A—Signaling by GPCR—DRD4—conduct disorder	4.18e-05	0.000402	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—DRD4—conduct disorder	4.17e-05	0.000401	CbGpPWpGaD
Sertindole—HTR1B—Signaling by GPCR—HTR2A—conduct disorder	4.14e-05	0.000399	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	4.09e-05	0.000394	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—WASF1—conduct disorder	4.09e-05	0.000393	CbGpPWpGaD
Sertindole—DRD4—Signaling by GPCR—HTR2A—conduct disorder	4.08e-05	0.000392	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—WASF1—conduct disorder	4.07e-05	0.000391	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—CGA—conduct disorder	4.01e-05	0.000386	CbGpPWpGaD
Sertindole—DRD3—GPCR downstream signaling—HTR2A—conduct disorder	3.99e-05	0.000384	CbGpPWpGaD
Sertindole—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	3.99e-05	0.000384	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—HTR2A—conduct disorder	3.91e-05	0.000376	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—WASF1—conduct disorder	3.89e-05	0.000375	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—DRD4—conduct disorder	3.86e-05	0.000371	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—DRD4—conduct disorder	3.83e-05	0.000369	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	3.8e-05	0.000366	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—DRD4—conduct disorder	3.75e-05	0.000361	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—HTR2A—conduct disorder	3.69e-05	0.000355	CbGpPWpGaD
Sertindole—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	3.62e-05	0.000348	CbGpPWpGaD
Sertindole—DRD3—Signaling by GPCR—HTR2A—conduct disorder	3.62e-05	0.000348	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—WASF1—conduct disorder	3.59e-05	0.000345	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—WASF1—conduct disorder	3.53e-05	0.00034	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—WASF1—conduct disorder	3.53e-05	0.000339	CbGpPWpGaD
Sertindole—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	3.48e-05	0.000334	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—WASF1—conduct disorder	3.46e-05	0.000333	CbGpPWpGaD
Sertindole—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.46e-05	0.000333	CbGpPWpGaD
Sertindole—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	3.31e-05	0.000318	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—DRD4—conduct disorder	3.28e-05	0.000315	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—DRD4—conduct disorder	3.28e-05	0.000315	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—WASF1—conduct disorder	3.21e-05	0.000309	CbGpPWpGaD
Sertindole—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	3.16e-05	0.000304	CbGpPWpGaD
Sertindole—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	3.14e-05	0.000302	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—CGA—conduct disorder	3.13e-05	0.000301	CbGpPWpGaD
Sertindole—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	3.05e-05	0.000294	CbGpPWpGaD
Sertindole—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	3.01e-05	0.000289	CbGpPWpGaD
Sertindole—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	3e-05	0.000288	CbGpPWpGaD
Sertindole—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	2.94e-05	0.000283	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—DRD4—conduct disorder	2.86e-05	0.000275	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.84e-05	0.000274	CbGpPWpGaD
Sertindole—DRD2—Signaling by GPCR—HTR2A—conduct disorder	2.77e-05	0.000267	CbGpPWpGaD
Sertindole—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	2.73e-05	0.000263	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—DRD4—conduct disorder	2.72e-05	0.000262	CbGpPWpGaD
Sertindole—HRH1—Signaling by GPCR—HTR2A—conduct disorder	2.72e-05	0.000262	CbGpPWpGaD
Sertindole—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	2.67e-05	0.000257	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—HTR2A—conduct disorder	2.52e-05	0.000242	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—DRD4—conduct disorder	2.51e-05	0.000241	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—HTR2A—conduct disorder	2.5e-05	0.000241	CbGpPWpGaD
Sertindole—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	2.48e-05	0.000239	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—DRD4—conduct disorder	2.47e-05	0.000238	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—DRD4—conduct disorder	2.46e-05	0.000237	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—HTR2A—conduct disorder	2.45e-05	0.000235	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—DRD4—conduct disorder	2.42e-05	0.000233	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—HTR2A—conduct disorder	2.41e-05	0.000232	CbGpPWpGaD
Sertindole—ADRA2A—Hemostasis—EP300—conduct disorder	2.29e-05	0.00022	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—DRD4—conduct disorder	2.25e-05	0.000216	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—COMT—conduct disorder	2.16e-05	0.000208	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—MAOA—conduct disorder	2.15e-05	0.000207	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—HTR2A—conduct disorder	2.14e-05	0.000206	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	2.14e-05	0.000206	CbGpPWpGaD
Sertindole—HTR1F—Signaling Pathways—EP300—conduct disorder	2.07e-05	0.000199	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—CGA—conduct disorder	2.04e-05	0.000197	CbGpPWpGaD
Sertindole—HTR1E—Signaling Pathways—EP300—conduct disorder	1.95e-05	0.000188	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—HTR2A—conduct disorder	1.86e-05	0.000179	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.85e-05	0.000178	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	1.78e-05	0.000171	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—HTR2A—conduct disorder	1.64e-05	0.000158	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—HTR2A—conduct disorder	1.61e-05	0.000155	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	1.58e-05	0.000152	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	1.47e-05	0.000141	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—COMT—conduct disorder	1.41e-05	0.000136	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—MAOA—conduct disorder	1.4e-05	0.000135	CbGpPWpGaD
Sertindole—HTR6—Signaling Pathways—EP300—conduct disorder	1.33e-05	0.000128	CbGpPWpGaD
Sertindole—HTR1D—Signaling Pathways—EP300—conduct disorder	1.32e-05	0.000127	CbGpPWpGaD
Sertindole—HTR1B—Signaling Pathways—EP300—conduct disorder	1.3e-05	0.000125	CbGpPWpGaD
Sertindole—DRD4—Signaling Pathways—EP300—conduct disorder	1.28e-05	0.000123	CbGpPWpGaD
Sertindole—ADRA1D—Signaling Pathways—EP300—conduct disorder	1.13e-05	0.000109	CbGpPWpGaD
Sertindole—DRD3—Signaling Pathways—EP300—conduct disorder	1.13e-05	0.000109	CbGpPWpGaD
Sertindole—HTR1A—Signaling Pathways—EP300—conduct disorder	9.88e-06	9.5e-05	CbGpPWpGaD
Sertindole—HTR2C—Signaling Pathways—EP300—conduct disorder	9.83e-06	9.46e-05	CbGpPWpGaD
Sertindole—ADRA1B—Signaling Pathways—EP300—conduct disorder	9.41e-06	9.05e-05	CbGpPWpGaD
Sertindole—ADRA2A—Metabolism—EP300—conduct disorder	9.28e-06	8.93e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—COMT—conduct disorder	9.22e-06	8.87e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—MAOA—conduct disorder	9.16e-06	8.81e-05	CbGpPWpGaD
Sertindole—DRD2—Signaling Pathways—EP300—conduct disorder	8.67e-06	8.34e-05	CbGpPWpGaD
Sertindole—HTR2A—Signaling Pathways—EP300—conduct disorder	8.53e-06	8.21e-05	CbGpPWpGaD
Sertindole—HRH1—Signaling Pathways—EP300—conduct disorder	8.51e-06	8.19e-05	CbGpPWpGaD
Sertindole—ADRA1A—Signaling Pathways—EP300—conduct disorder	8.36e-06	8.04e-05	CbGpPWpGaD
Sertindole—ADRA2A—Signaling Pathways—EP300—conduct disorder	7.76e-06	7.47e-05	CbGpPWpGaD
Sertindole—CYP2D6—Metabolism—EP300—conduct disorder	6.05e-06	5.82e-05	CbGpPWpGaD
Sertindole—CYP3A4—Metabolism—EP300—conduct disorder	3.96e-06	3.81e-05	CbGpPWpGaD
